chemistry 125: lecture 27 november 6, 2009 communicating molecular structure in diagrams and words...
Post on 21-Dec-2015
214 views
TRANSCRIPT
Chemistry 125: Lecture 27November 6, 2009
Communicating Molecular Structure in Diagrams and Words
It is important that chemists agree on notation and nomenclature in order to communicate
molecular constitution and configuration. Clear notation also aids clarity of thought. The
conventional 1891 Fischer projection, which has been indispensable in understanding sugar
configurations for over a century, was invented in order to count stereoisomers. Ambiguity in
diagrams or words has led to multibillion dollar patent disputes involving popular
pharmaceuticals. International agreements provide descriptive, unambiguous, unique,
systematic “IUPAC” names that are reasonably convenient for most organic molecules of
modest molecular weight. Also in 1891 Fischer devised the D,L “genealogical” scheme to
describe relative configurations, but it can be cumbersome or ambiguous.For copyright
notice see final page of this file
Configurational Isomer Counting
n "Stereogenic Centers" 2n isomers?
No, because of meso compounds
"Next we consider a symmetrical formula:
C(R1 R2 R3)C(R4 R4)C(R1 R2 R3) , and
C(R1 R2 R3)C(R4 R5)C(R1 R2 R3) as well.
As is easily conceived from the forgoingdiscussion, they lead to only three isomers."
van't Hoff (1877)(Baeyer & Fischer gave up on using bread rolls.)
H OH
H OH
HO H
COOH
COOH
Trihydroxyglutaric Acids
1 2 3 (2)
(1)(4)(3)42 meso isomers and a pair of enantiomers /
23 = 8
Meso?
?
HOOC-CH(OH)-CH(OH)-CH(OH)-COOH
easy with Fischer projections
H OH H OH H OH H OH
H OH HO H
H OH HO H H OH HO H
H OH HO H
H OH H OH
H OH H OH HO HHO H
HO HHO H
HO H HO HHO H HO H
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
4
COOH
COOH
Halichondrin B: A Marine Natural Product with Potent In Vitro and In Vivo Antitumor Activity
Discovery of E7389 Starting From the Halichondrin B C.1-C.38 Macrolide
O
O
O
O O
O
O
O
O
HO
HO
MeO
O
H
H H
MeH
H
H
O O
OMe
OO
O
O
O
OO
Me
HH
H
H
H2N
OH
E7389halichondrin B C.1-C.38 macrolide
"In Vitro and In Vivo Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B"M.J. Towle, K.A. Salvato, J. Budrow, B.F. Wels, G. Kuznetsov, K.K. Aalfs, S. Welsh, W. Zheng, B.M.Seletsky, M.H. Palme, G.J. Habgood, L.A. Singer, L.V. DiPietro, Y.Wang, J.J. Chen, D.A. Quincy, A.DavisK. Yoshimatsu, Y. Kishi, M.J. Yu, and B.A. Littlefield, Cancer Res., February 1, 2001; 61(3): 1013-1021
SARActive Fragment
of Halichondrin B "Simplified" Versionof Active Fragmentis Drug Candidate
E7389
219 > 500,000 configurational isomers!
19 “stereogenic centers”Structure-ActivityRelationship Study
E7389 Phase III Nov 2008
ClinicalTrials.gov currently has 80,975 trials with locations in 170 countries. (Nov. 3, 2009)
(Nov. 3, 2009)(Nov. 7, 2008)
Lipitor
The world’s best selling drug ($10.86 billion in 2004)
A $10,000,000,000 Problem in Stereochemical Notation
Oct. 12, 2005
NEW YORK - Pfizer Inc. won a significant victory on Wednesday when a British judge upheld a key patent covering its blockbuster cholesterol drug Lipitor in the United Kingdom but the medication still faces a similar yet more important case in the United States.
Judge Nicholas Pumfrey upheld the patent covering atorvastatin, Lipitor’s active ingredient, but ruled that another patent was invalid. Indian pharmaceutical company Ranbaxy Laboratories Ltd. had challenged both patents, and was joined by Britain’s Arrow Generics Ltd. against the second patent that was ruled invalid.
Pfizer said the decision upholding the exclusivity of the patent covering atorvastatin until November 2011 was an important victory for scientists.
(Analogus decision 8/2/2006 in U.S. Court of Appeals)
…
What is Patented?single enantiomer (Lipitor, drawn in figure)
or racemate (described in text)
Number of permutations much greater than the
total number of protons, neutrons, and electrons
in the Solar system!
OH -OCa+2
F
O
i-PrH-N
Opinion of Sir Nicholas Pumfrey
In my view, the claim covers the racemate and the individual enantiomers.
In the '633 patent, it is absolutely clear from context throughout that formula (I) is being used to denote a racemate. In my judgment, every time the skilled person sees formula I or formula X he will see it with eyes that tell him that in that racemate, there is a single enantiomer that is the effective compound, and that he can resolve the racemate using conventional techniques to extract that enantiomer.
In the '633 patent, it is absolutely clear from context throughout that formula (I) is being used to denote a racemate.
When one comes to claim 1, which echoes the purpose of the invention with its conventional reference to pharmaceutically acceptable salts, he will, in my judgment, continue to see the formulae in this light.
I X
Thus Pfizer’s later patent on the single enantiomer is an invalid repeat, and patent protection will run out three years earlier !
Constitutional Nomenclature Conventions
Geneva (1892)
Formal name should be:• Clearly Descriptive
• Unambiguous
• Unique
• Manageable
Unfortunately "Amide" means
both R2N- and RCONH2
(e.g. Quick, Easy, Short, Pronounceable)
Indexing Alternatives: composition, computer graphics
Composition, Constitution,Configuration, Conformation
IUPAC, International Unionof Pure & Applied Chemistryhttp://www.chem.qmw.ac.uk/iupac/http://acdlabs.com/iupac/nomenclature
One name one structure
One structure one name
i.e. Stereochemistry
Cl
Br
Systematic Constitutional Nomenclature
Choose the “Main Chain”for Greek Root Name
Number the Chain Atoms
Name Substituents
Alphabetize (& Count)
• Longest
• Most Substituents
• Lowest number atFirst Difference
Cl
Br octane
Cl
Br
12
132
34
56
7
7-bromo-2-chloro-3-ethyl-6,7-dimethylnonane
Cl
Br ?
3
(to give simpler names)
(1-chloroethyl)
methyl
methylbromo
ethyl
chloro
http://acdlabs.com/iupac/nomenclature/93/r93_338.htm
WOW!
Thank God for pictures and computer graphics.
Some Useful Non-Systematic Names
Isobutane Isopentane Neopentane
NeopentylIsopropyl sec-Butyl tert-Butyl
XX X
X
Nomenclature Drillavailable on course website.
Tartaric Acid IsomersCOOH
COOH
H
OH
HO
H
COOH
COOH
OH
H
H
HO
Configurational Nomenclature
COOH
COOH
OH
OH
H
H
COOH
COOH
H
OH
HO
H
COOH
COOH
OH
H
H
HO
CHO
CH2OH
OHH
Defined as “D”-glyceraldehyde (Fischer’s Guess)
m.p.[]D
140°C0°
170°C+13°
170°C-13°(meso) (dextro +) (laevo -)
Phenomenological
Multi-StepSynthesis
D-Tartaric Acid
Whynot?
Genealogical (Fischer, 1891)
d-(+)-glyceraldehyde
HOCH2CH(OH)CHO
Relative (by synthesis) to
?
D/L designation isambiguous withouthaving a detailed synthesis recipe or a convention.
?
(1978)
First of 210 Tables
D
D
Glyceraldehyde
Lactic Acid
>2000 Compoundsin the 210 Tables
Problem for Monday:Consider HOMO/LUMO
alternatives during the reaction of HI with
1,3-butanediol to give 4-iodo-2-butanol
Paul D. Bartlettage 24
24 years old
End of Lecture 27Nov. 6, 2009
Copyright © J. M. McBride 2009. Some rights reserved. Except for cited third-party materials, and those used by visiting speakers, all content is licensed under a Creative Commons License (Attribution-NonCommercial-ShareAlike 3.0).
Use of this content constitutes your acceptance of the noted license and the terms and conditions of use.
Materials from Wikimedia Commons are denoted by the symbol .
Third party materials may be subject to additional intellectual property notices, information, or restrictions.
The following attribution may be used when reusing material that is not identified as third-party content: J. M. McBride, Chem 125. License: Creative Commons BY-NC-SA 3.0